The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication
and prevent disease progression to a more severe form. However, the timing of antiviral …

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has posed a serious threat to public health and has quickly become a global concern. The …

Purpose Low vitamin D in COVID-19 have been related to worse outcomes. However, most
of the studies conducted so far were not-controlled and retrospective, including biases …

Angiotensin converting enzyme 2 (ACE2), a transmembrane glycoprotein, is an important
part of the renin-angiotensin system (RAS). In the COVID-19 epidemic, it was found to be the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a global health
crisis after its emergence in 2019. Replication of the virus is initiated by binding of the viral …

It is urgent to understand the infection mechanism of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) for the prevention and treatment of COVID-19. The infection of …

SARS-CoV-2 uses the receptor binding domain (RBD) of its spike protein to recognize and
infect host cells by binding to the cell surface receptor angiotensin converting enzyme 2 …

Here, we present evidence that caveolae-mediated endocytosis using LDLR is the pathway
for SARS-CoV-2 virus internalization in the ocular cell line ARPE-19. Firstly, we found that …

Since the spread of the deadly virus SARS-CoV-2 in late 2019, researchers have restlessly
sought to unravel how the virus enters the host cells. Some proteins on each side of the …

Highly mutated SARS-CoV-2 is known aetiological factor for COVID-19. Here, we have
demonstrated that the receptor binding domain (RBD) of the spike protein can interact with …